No. |
Page Title |
URI |
1 |
Daiichi Sankyo |
https://www.daiichisankyo.com/ |
2 |
Careers |
https://www.daiichisankyo.com/careers/ |
3 |
Press Releases |
https://www.daiichisankyo.com/media/press_release/ |
4 |
Our Pipeline |
https://www.daiichisankyo.com/rd/pipeline/ |
5 |
Shareholders & Investors |
https://www.daiichisankyo.com/investors/ |
6 |
Products |
https://www.daiichisankyo.com/products/ |
7 |
Worldwide |
https://www.daiichisankyo.com/worldwide/ |
8 |
Media |
https://www.daiichisankyo.com/media/ |
9 |
About Us |
https://www.daiichisankyo.com/about_us/ |
10 |
Financial Results Presentation Material |
https://www.daiichisankyo.com/investors/library/quarterly_result/ |
11 |
IR Presentation Material |
https://www.daiichisankyo.com/investors/library/materials/ |
12 |
Research & Development |
https://www.daiichisankyo.com/rd/ |
13 |
IR News |
https://www.daiichisankyo.com/investors/ir_news/ |
14 |
Contact us |
https://www.daiichisankyo.com/contact/ |
15 |
Our Stories |
https://www.daiichisankyo.com/our_stories/ |
16 |
Our Leadership |
https://www.daiichisankyo.com/about_us/mission-strength/leadership/ |
17 |
Our Areas of Interest |
https://www.daiichisankyo.com/rd/open_innovation/our_interests/ |
18 |
Value Report |
https://www.daiichisankyo.com/investors/library/annual_report/ |
19 |
Our Mission and Vision |
https://www.daiichisankyo.com/about_us/mission-strength/vision/ |
20 |
Global Presence |
https://www.daiichisankyo.com/about_us/corporate_info/group/ |
21 |
Clinical Trials, Study Results and Plain Language Results Summaries |
https://www.daiichisankyo.com/rd/clinical_trials/list/ |
22 |
Promoting the Success and Development of a Diverse Range of People Who Create Our Competitive Advantages |
https://www.daiichisankyo.com/sustainability/our_workplace/ |
23 |
5-Year Business Plan |
https://www.daiichisankyo.com/about_us/mission-strength/vision/mid_term/ |
24 |
Daiichi Sankyo Launches “Tarlige? Tablets” for Pain Treatment in Japan |
https://www.daiichisankyo.com/media/press_release/detail/index_3194.html |
25 |
Corporate Information |
https://www.daiichisankyo.com/about_us/corporate_info/ |
26 |
Partnering |
https://www.daiichisankyo.com/partnering/ |
27 |
Quarterly Results FY2023 |
https://www.daiichisankyo.com/investors/library/quarterly_result/2023.html |
28 |
Our R&D Strategy & Operations |
https://www.daiichisankyo.com/rd/strategy_operations/ |
29 |
Sustainability |
https://www.daiichisankyo.com/sustainability/ |
30 |
History as Pharma Innovator |
https://www.daiichisankyo.com/about_us/mission-strength/history/ |
31 |
Open Innovation |
https://www.daiichisankyo.com/rd/open_innovation/ |
32 |
Inquiry Form |
https://www.daiichisankyo.com/contact/form/index.php |
33 |
Adopting advanced technologies and promoting DX (digital transformation) to contribute to the company’s growth |
https://www.daiichisankyo.com/our_stories/detail/index_4494.html |
34 |
Message from Our CEO |
https://www.daiichisankyo.com/about_us/mission-strength/top_message/ |
35 |
Information on WCLC/ESMO 2024 highlights has been posted. |
https://www.daiichisankyo.com/investors/ir_news/detail/index_4505.html |
36 |
Environmental Management System |
https://www.daiichisankyo.com/sustainability/the_environment/policy-system/ |
37 |
Financial Summary |
https://www.daiichisankyo.com/investors/financial_highlights/date_summary/ |
38 |
ESG Data |
https://www.daiichisankyo.com/sustainability/performance-reports/esg-data/ |
39 |
Inquiries about Open Innovation |
https://www.daiichisankyo.com/rd/open_innovation/contact/form/index.php |
40 |
Corporate Governance Structure & Effort |
https://www.daiichisankyo.com/about_us/governance/structure/ |